paclitaxel has been researched along with Thymus Neoplasms in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.45) | 18.2507 |
| 2000's | 6 (20.69) | 29.6817 |
| 2010's | 15 (51.72) | 24.3611 |
| 2020's | 7 (24.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CH; Chang, YL; Chen, JS; Hsu, FM; Huang, YL; Lee, JM; Lin, CC; Ma, WL; Yang, JC | 1 |
| Benetti, B; Comacchio, GM; Di Liso, E; Guarneri, V; Menichetti, A; Pasello, G; Rea, F | 1 |
| Fukui, T; Hisashi, M; Hosotani, S; Igawa, S; Kasajima, M; Kusuhara, S; Manabe, H; Manaka, H; Nakahara, Y; Naoki, K; Oguri, A; Sasaki, J; Sato, T; Yamamoto, M | 1 |
| Amano, H; Fujita, T; Hirano, S; Inazaki, T; Ishikawa, R; Nakamura, M; Nakamura, S; Urano, Y | 1 |
| Akamatsu, H; Asao, T; Goto, Y; Ikeda, S; Kaira, K; Ko, R; Mimori, T; Mizutani, H; Mori, K; Shukuya, T; Sugawara, S; Suzuki, T; Tachihara, M; Takahashi, K; Takayama, K; Tanaka, H; Tanizaki, J; Tsubata, Y; Zenke, Y | 1 |
| An, T; Chen, H; Dong, Z; Jia, B; Li, J; Shi, A; Wang, Y; Wang, Z; Wu, M; Yang, S; Yang, X; Zhao, J; Zhong, J; Zhuo, M | 1 |
| Carlan, SJ; Castaneira, G; Field, Z; Kropf, J; Luc, LT; Oriala, C; Rico, A | 1 |
| Chakraborty, K; Costello, PN; Manthri, S; Rehman, HH | 1 |
| Pandey, D; Shepro, DS | 1 |
| Han, L; Li, W; Ye, Z | 1 |
| Berardi, R; Broggini, M; Fabbri, A; Ganzinelli, M; Garassino, MC; Hollander, L; Imbimbo, M; Marabese, M; Marino, M; Ottaviano, M; Palmieri, G; Pasello, G; Petrini, I; Pruneri, G; Rulli, E; Torri, V; Trama, A; Vitali, M; Zucali, P | 1 |
| Daga, H; Fukuoka, J; Hirai, F; Ichinose, Y; Iwamoto, Y; Kimura, T; Kogure, Y; Nakagawa, K; Nakanishi, Y; Ono, A; Sasaki, H; Seto, T; Shimizu, J; Taguchi, K; Takeda, K; Tanaka, K; Yamanaka, T | 1 |
| Asakawa, K; Hayashi, Y; Ishikawa, D; Kagamu, H; Kondo, R; Miura, S; Narita, I; Ohshima, Y; Okajima, M; Sakagami, T; Tanaka, J; Tanaka, T; Watanabe, S; Yoshizawa, H | 1 |
| Asakawa, K; Goto, S; Iino, N; Kagamu, H; Kazama, JJ; Miura, S; Moro, H; Narita, I; Nozaki, K; Okajima, M; Sakai, T; Watanabe, S; Yamamoto, S; Yoshizawa, H | 1 |
| Ajgal, Z; Alexandre, J; Boudou-Rouquette, P; Cessot, A; Chapuis, N; Emile, G; Fontenay, M; Goldwasser, F; Huillard, O; Tigaud, JM | 1 |
| Ahn, JS; Ahn, MJ; Kim, HS; Lee, JY; Lee, SH; Lim, SH; Moon, SH; Park, K; Sun, JM | 1 |
| Endo, M; Igawa, S; Kaira, K; Murakami, H; Naito, T; Nakamura, Y; Ono, A; Shukuya, T; Takahashi, T; Tamiya, A; Tsuya, A; Yamamoto, N | 1 |
| Becherer, A; De Vries, A; Drexel, H; Gasser, K; Gruber-Moesenbacher, U; Lang, A; Muendlein, A; Schuster, A; Winder, T | 1 |
| Hayashi, N; Igawa, S; Iida, Y; Katono, K; Kimura, Y; Maki, S; Makita, S; Masuda, N; Onoda, S; Otani, S; Takakura, A; Yamamoto, M; Yanagisawa, N | 1 |
| Aisner, SC; Johnson, DH; Langer, CJ; Lee, JW; Lemma, GL; Loehrer, PJ; Tester, WJ | 1 |
| Furugen, M; Horinouchi, H; Kubota, K; Nokihara, H; Sekine, I; Tamura, T; Tsuta, K; Yamamoto, N | 1 |
| Funada, Y; Itoh, T; Kobayashi, K; Kotani, Y; Nagai, H; Nagano, T; Nakata, K; Nishimura, Y; Sakashita, A; Tomita, N | 1 |
| Goto, T; Korenaga, T; Morio, A; Nakahara, K; Ohse, Y; Tahara, M; Yakumaru, K | 1 |
| Greene, MA; Malias, MA | 1 |
| Aker, S; Arslan, M; Demiray, M; Evrensel, T; Kanat, O; Kurt, E; Manavoglu, O | 1 |
| Aoki, Y; Eguchi, T; Ichinose, Y; Kojo, M; Maruyama, R; Nishiyama, K; Okamoto, T; Seto, T; Suemitsu, R; Wataya, H | 1 |
| St Hill, S | 1 |
| Berruti, A; Dogliotti, L; Gorzegno, G; Tampellini, M | 1 |
| Hazama, K; Kagisaki, K; Matsuda, H; Miyoshi, S; Ohta, M; Shintani, Y | 1 |
3 review(s) available for paclitaxel and Thymus Neoplasms
| Article | Year |
|---|---|
Chemotherapy improves thymoma-associated graft-versus-host-disease-like erythroderma.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Cisplatin; Dermatitis, Exfoliative; Diagnosis, Differential; Drug Therapy, Combination; Graft vs Host Disease; Humans; Male; Methylprednisolone; Middle Aged; Paclitaxel; Skin; Thymoma; Thymus Neoplasms | 2011 |
Efficacy of induction chemoradiotherapy in thymic cancer: report of a successful case and review of the literature.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Radiography, Thoracic; Remission Induction; Thymus Neoplasms | 2002 |
Thymic carcinoma successfully resected with superior vena cava after chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Paclitaxel; Pericardial Effusion; Pleural Effusion, Malignant; Taxoids; Thymus Neoplasms; Vena Cava, Superior | 2001 |
5 trial(s) available for paclitaxel and Thymus Neoplasms
| Article | Year |
|---|---|
Study Design and Rationale for Marble Study: A Phase II Trial of Atezolizumab (MPDL3280A) Plus Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Thymic Carcinoma (JTD2101).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Programmed Cell Death 1 Receptor; Thymoma; Thymus Neoplasms | 2023 |
RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Prognosis; Ramucirumab; Research Design; Thymoma; Thymus Neoplasms; Young Adult | 2018 |
A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Thymoma; Thymus Neoplasms | 2015 |
A Prospective Phase II Study of Cisplatin and Cremophor EL-Free Paclitaxel (Genexol-PM) in Patients with Unresectable Thymic Epithelial Tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Male; Middle Aged; Neoplasms, Glandular and Epithelial; Paclitaxel; Prospective Studies; Thymus Neoplasms | 2015 |
Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Disease-Free Survival; Female; Humans; Male; Middle Aged; Paclitaxel; Thymoma; Thymus Neoplasms | 2011 |
21 other study(ies) available for paclitaxel and Thymus Neoplasms
| Article | Year |
|---|---|
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Paclitaxel; Platinum; Retrospective Studies; Thymoma; Thymus Neoplasms | 2022 |
Induction chemotherapy with carboplatin and paclitaxel for thymoma in acute respiratory distress due to myasthenia gravis: a case report.
Topics: Carboplatin; Humans; Induction Chemotherapy; Myasthenia Gravis; Paclitaxel; Respiratory Distress Syndrome; Respiratory Insufficiency; Retrospective Studies; Thymoma; Thymus Neoplasms | 2022 |
Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma.
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Middle Aged; Paclitaxel; Retrospective Studies; Thymoma; Thymus Neoplasms | 2023 |
Drastic response to rechallenge with calboplatin plus nab-paclitaxel after immunotherapy in a patient with advanced thymic carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Immunotherapy; Lung Neoplasms; Paclitaxel; Thymoma; Thymus Neoplasms | 2023 |
Optimal first-line treatment for advanced thymic carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Survival Analysis; Thymoma; Thymus Neoplasms; Treatment Outcome; Young Adult | 2019 |
A Case of Thymic Carcinoma with Bone and Cerebral Metastases Treated with Stereotactic Radiosurgery and Chemotherapy.
Topics: Bone Neoplasms; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Radiosurgery; Thymoma; Thymus Neoplasms; Treatment Outcome | 2019 |
Thymic basaloid carcinoma: a rare clinical entity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Female; Humans; Liver Neoplasms; Middle Aged; Neoplasms, Second Primary; Paclitaxel; Thymus Neoplasms | 2019 |
Thymic cancer in lynch syndrome: an unusual association.
Topics: Antineoplastic Agents; Carboplatin; Colorectal Neoplasms, Hereditary Nonpolyposis; Dasatinib; Dexamethasone; Diagnosis, Differential; Drug Therapy, Combination; Fatal Outcome; Female; Glucocorticoids; Humans; Lung Neoplasms; Middle Aged; Paclitaxel; Thymus Neoplasms | 2020 |
Primary pericardial angiosarcoma: A case report.
Topics: Adult; Doxorubicin; Heart Neoplasms; Hemangiosarcoma; Humans; Male; Mediastinal Neoplasms; Paclitaxel; Pericardium; Thymus Neoplasms; Young Adult | 2022 |
[A case of thymic cancer effectively treated by weekly paclitaxel combined with carboplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Neoplasm Staging; Paclitaxel; Thymus Neoplasms; Tomography, X-Ray Computed | 2014 |
Advanced thymic cancer treated with carboplatin and paclitaxel in a patient undergoing hemodialysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Humans; Male; Middle Aged; Paclitaxel; Renal Dialysis; Thymoma; Thymus Neoplasms; Treatment Outcome | 2015 |
Risk factors for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia over time: assessment of monocyte count and baseline clinical parameters.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Case-Control Studies; Doxorubicin; Female; Hand-Foot Syndrome; Hematologic Diseases; Humans; Leukocyte Count; Male; Middle Aged; Monocytes; Ovarian Neoplasms; Paclitaxel; Pilot Projects; Polyethylene Glycols; Retrospective Studies; Sarcoma; Stomatitis; Thymus Neoplasms; Young Adult | 2015 |
Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Thymoma; Thymus Neoplasms | 2010 |
Advanced inoperable type B3 thymoma: monitoring of a novel therapeutic approach with radio-chemotherapy and sorafenib by FDG-PET and CT.
Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Doxorubicin; Epirubicin; Female; Humans; Image Processing, Computer-Assisted; Middle Aged; Paclitaxel; Radiation-Sensitizing Agents; Radiography; Radionuclide Imaging; Taxoids; Thymoma; Thymus Neoplasms; Treatment Outcome | 2010 |
[A case of recurrent invasive thymic cancer showing a stable disease to carboplatin plus paclitaxel].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Thymus Neoplasms | 2010 |
Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Retrospective Studies; Therapeutics; Thymus Neoplasms | 2011 |
Aggressive multimodality treatment of invasive thymic carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Postoperative Care; Radiotherapy, Adjuvant; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed | 2003 |
Successful treatment of thymoma-associated erythroid hypoplasia and thrombocytopenia with paclitaxel.
Topics: Adult; Anemia, Aplastic; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Humans; Male; Paclitaxel; Thrombocytopenia; Thymoma; Thymus Neoplasms; Treatment Outcome | 2005 |
Persistent and aggressive treatment for thymic carcinoma. Results of a single-institute experience with 25 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Thymoma; Thymus Neoplasms; Treatment Outcome | 2006 |
Thymic carcinoma.
Topics: Aged; Antineoplastic Agents; Carboplatin; Humans; Male; Paclitaxel; Thymus Neoplasms; Treatment Outcome | 2007 |
Objective response to epirubicin and lonidamine. A case of advanced thymoma previously treated with the ADOC scheme and unresponsive to paclitaxel plus cyclophosphamide.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Indazoles; Middle Aged; Paclitaxel; Remission Induction; Salvage Therapy; Thymoma; Thymus Neoplasms; Vincristine | 1997 |